Bubs Australia Ltd. · ASX:BUB

Bubs Australia — ShareCafe Presentation March 2024

28 slides from Bubs Australia's conference presentation, Mar 15, 2024

  1. Slide 1: ShareCafe Presentation

    ShareCafe Presentation | 15 March 2024 ShareCafe Presentation For personal use only 15 March 2024 Slide 1

  2. Slide 2: Disclaimer

    ShareCafe Presentation | 15 March 2024 DISCLAIMER This presentation is in summary form and is not necessarily complete. It should be read together with the Company’s other announcements lodged with the Australian Securities Exchange. For personal use only This presentation contains information that

  3. Slide 3: Contents

    ShareCafe Presentation | 15 March 2024 Contents For personal use only Section 1: Bubs Investment Proposition Section 2: Australia Market Context Section 3: Strategy Update Section 4: H1 FY24 Results Recap Section 5: Progress To Date & Outlook Slide 3

  4. Slide 4: Section 1: Bubs Investment Proposition

    For personal use only ShareCafe Presentation | 15 March 2024 Section 1: Bubs Investment Proposition Slide 4

  5. Slide 5: The Bubs Investment Proposition

    ShareCafe Presentation | 15 March 2024 THE BUBS INVESTMENT PROPOSITION Bubs is a global market leader with a differentiated premium goat-based product offering, operating in both the IMF and Adult Nutrition categories. For personal use only Differentiated premium goat- US $100B+ global addressable b

  6. Slide 6: Section 2: Australia Market Context

    For personal use only ShareCafe Presentation | 15 March 2024 Section 2: Australia Market Context Slide 6

  7. Slide 7: Market Leader in Goat Formula in Australia

    ShareCafe Presentation | 15 March 2024 MARKET LEADER IN GOAT FORMULA IN AUSTRALIA Bubs holds 52% of the domestic goat IMF1 For personal use only $5,000 Bubs Quarterly Revenue & Market Share (%)1 6% 5.3% 52% $4,000 5% market market 4% share of AU share of $3,000 IMF1 goat IMF1 A$’000 3% $2,000 2% $1,

  8. Slide 8: Section 3: Strategy Update

    For personal use only ShareCafe Presentation | 15 March 2024 Section 3: Strategy Update Slide 8

  9. Slide 9: Strategy Update

    ShareCafe Presentation | 15 March 2024 STRATEGY UPDATE Bubs’ 5 point plan to responsibly manage capital and maximise shareholder value For personal use only 1 2 3 4 5 USA CHINA PORTFOLIO SWEAT THE WORKING GROWTH RESET OPTIMISATION ASSETS CAPITAL ENGINE GROW & MAXIMISE SHAREHOLDER VALUE 9 Slide 9

  10. Slide 10: USA Growth Engine

    For personal use only ShareCafe Presentation | 15 March 2024 USA GROWTH ENGINE Strategy Update Slide 10

  11. Slide 11: USA Contributed 46% of Revenue in H1 FY24

    ShareCafe Presentation | 15 March 2024 USA CONTRIBUTED 46% OF REVENUE IN H1 FY24 USA continues to be Bubs’ most important region For personal use only  In FY22, Bubs strategically pivoted to focus on growth in the USA.  USA contributed 46% of total revenue in H1 FY24, up from 40% in FY23. Total US

  12. Slide 12: USA Penetration

    ShareCafe Presentation | 15 March 2024 USA PENETRATION Bubs products are ranged in over 5,800 physical stores across the US, in addition to e-commerce channels For personal use only Slide 12

  13. Slide 13: USA Growth Engine

    ShareCafe Presentation | 15 March 2024 $18.2m c. 85% revenue USA GROWTH ENGINE increase vs pcp Total Scan USD#039;s AMAZON & Bricks & Mortar $10,000,000 Combined1&2 Total USA revenue of $18.2m in H1 FY24, For personal use only  $9,000,000 an 85% increase from H1 FY23. $8,000,000  #1 goat milk in the

  14. Slide 14: Regulatory Pathway

    ShareCafe Presentation | 15 March 2024 REGULATORY PATHWAY Bubs is on track for permanent FDA approval by Oct-25, with the USA poised to deliver substantial growth via e-commerce and traditional retail For personal use only May 2022: FDA exercised July 2022: FDA announces Dec 2022: FDA issues Bubs a

  15. Slide 15: Regulatory Costs

    ShareCafe Presentation | 15 March 2024 REGULATORY COSTS End to end costs associated with obtaining FDA regulatory approval estimated at c. $9.9M For personal use only Actual Forecast Slide 15

  16. Slide 16: China Reset

    For personal use only ShareCafe Presentation | 15 March 2024 CHINA RESET Strategy Update Slide 16

  17. Slide 17: China Revenue

    ShareCafe Presentation | 15 March 2024 CHINA REVENUE Bubs expects to achieve full year revenue growth in FY24 compared with FY23 For personal use only  Bubs’ China re-set strategy is well underway with two distributors appointed by Bubs to service the Chinese market in H1 FY24 China Revenue  The i

  18. Slide 18: Portfolio Optimisation

    For personal use only ShareCafe Presentation | 15 March 2024 PORTFOLIO OPTIMISATION Strategy Update Slide 18

  19. Slide 19: Portfolio Optimisation

    ShareCafe Presentation | 15 March 2024 PORTFOLIO OPTIMISATION Bubs is a global leader in infant & adult goat nutrition, with an estimated total addressable market size of A$4.5bn1 For personal use only Strategic Priority Update 1 Hero Brands – Bubs and Caprilac New look packaging for US and China in

  20. Slide 20: Sweat the Assets

    For personal use only ShareCafe Presentation | 15 March 2024 SWEAT THE ASSETS Strategy Update Slide 20

  21. Slide 21: Sweat the Assets

    ShareCafe Presentation | 15 March 2024 SWEAT THE ASSETS Bubs has commenced a second production shift at Deloraine, increasing utilisation to 70% For personal use only  Capital raising conducted in Nov-23 enabling Bubs to Deloraine Utilisation expand production to pursue growth.  Second shift produ

  22. Slide 22: Working Capital

    For personal use only ShareCafe Presentation | 15 March 2024 WORKING CAPITAL Strategy Update Slide 22

  23. Slide 23: Working Capital & Cash Flow

    ShareCafe Presentation | 15 March 2024 WORKING CAPITAL & CASH FLOW Bubs expects it will be cash flow positive with positive trading EBITDA in FY25 For personal use only Cash Burn in H1 FY24  Management target cash burn is $2.0m per month from Q2 FY241 for FY24.  Actual average monthly cash burn wa

  24. Slide 24: Section 4: H1 FY24 Results Recap

    For personal use only ShareCafe Presentation | 15 March 2024 Section 4: H1 FY24 Results Recap Slide 24

  25. Slide 25: H1 FY24 Performance

    ShareCafe Presentation | 15 March 2024 H1 FY24 PERFORMANCE Delivering on FY24 strategic priorities For personal use only GROSS GROSS BALANCE OPEX ratio PORTFOLIO REVENUE MARGIN SHEET $49.2m 38% 53% $29.5m IMF $27.4m cash +30% vs. H1 FY231 +3% vs. H1 FY232 53% vs. 78% in H1 FY233 +12% VS. pcp4 +$9.8m

  26. Slide 26: Section 5: Progress To Date & Outlook

    For personal use only ShareCafe Presentation | 15 March 2024 Section 5: Progress To Date & Outlook Slide 26

  27. Slide 27: FY24 Progress to Date & Outlook

    ShareCafe Presentation | 15 March 2024 FY24 PROGRESS TO DATE & OUTLOOK FY24 will see Bubs continue to work towards its strategic priorities outlined in the 5-point strategic plan, and target cash flow breakeven in FY25 For personal use only Strategic Priority Update 1 Forecast net revenue of $80m Tr

  28. Slide 28: Thank you

    For personal use only ShareCafe Presentation | 15 March 2024 Thank you Q&A investors@bubsaustralia.com Slide 28

Bubs Australia — ShareCafe Presentation March 2024 on 6ix